Cervical Cancer Diagnosis Protocol

In this study, patients with cervical cancer and healthy controls who were admitted to the hospital from February 2022 to June 2022 were collected. The choice was taken and the informed permission was signed by the patients and their families. Following admission, the patient’s conditions and the progress of the study were fully disclosed to them as well as to their families. The Zhengzhou University First Affiliated Hospital Ethics Committee has authorized this work (2022-KY-1341-002). The eligibility criteria are as follows: (1) Age: 18-72 years old; (2) All patients with cervical cancer were pathologically diagnosed; All healthy controls underwent detailed CT, MRI, and other imaging examinations. (3) All patients had not received pelvic and systemic concurrent chemoradiotherapy before admission, and the main organ functions were normal. (4) None of the participants had antibiotics administration 3 months before samples collection. And the two groups were matched by age and body mass index (BMI).